Search results
Nvidia will soar 21% to $1,000 as its new AI chip slams would-be rivals, Morgan Stanley says. It’s...
Fortune via Yahoo Finance· 1 day ago“We believe that growth from ABBV’s ex-Humira business (primarily Skyrizi, Rinvoq, and aesthetics)...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 10 hours agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
What's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Zacks via Yahoo Finance· 11 hours agoThe Zacks Consensus Estimate is pegged at $2.26 per share. AbbVie’s top line is expected to have...
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 days agoAbbVie’s top line is being driven by sales of new immunology drugs, Skyrizi and Rinvoq. The Zacks...
Gear Up for AbbVie (ABBV) Q1 Earnings: Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 1 day agoGet a deeper insight into the potential performance of AbbVie (ABBV) for the quarter ended March...
Artisan International Fund Q1 2024 Commentary
Seeking Alpha· 10 hours agoArtisan Partners is an independent investment management firm focused on providing high value-added, active investment strategies to sophisticated...
Big pharma: cautious optimism ahead of earnings season - analysts
Proactive Investors· 7 days agoLooking ahead to the pharmaceutical earnings season, UBS expressed cautious optimism when looking at...
AbbVie Inc. (NYSE:ABBV) to Post Q1 2024 Earnings of $2.21 Per Share, William Blair Forecasts
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at William Blair issued their Q1 2024 EPS estimates for AbbVie in a research note issued to investors on Wednesday, April 17th. William ...
FY2025 EPS Estimates for AbbVie Inc. (NYSE:ABBV) Lowered by Analyst
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Free Report) – Investment analysts at William Blair dropped their FY2025 EPS estimates for shares of AbbVie in a report released on Wednesday, April 17th. William Blair ...
AbbVie (NYSE:ABBV) Shares Up 1.8%
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shot up 1.8% on Thursday . The company traded as high as $167.44 and last traded at $167.14. BMO Capital Markets raised their price target on shares ...